Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  MDM2 antagonist RO5503781
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of RO5503781 as Single Agent or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NP28679, NCI-2013-01140, 2012-004882-41, NCT01773408
Start Over